Is neurotrophin-3 (NT-3): a potential therapeutic target for depression and anxiety?

A S de Miranda, J L V M de Barros, Antonio Lucio Teixeira

Expert opinion on therapeutic targets 2020 Dec

filter terms:

Introduction: Neurotrophin-3 (NT-3) is thought to play a role in the neurobiological processes implicated in mood and anxiety disorders. NT-3 is a potential pharmacological target for mood disorders because of its effects on monoamine neurotransmitters, regulation of synaptic plasticity and neurogenesis, brain-derived neurotrophic factor (BDNF) signaling boosting, and modulation of the hypothalamic-pituitary-adrenal (HPA) axis. The mechanisms underlying NT-3 anxiolytic properties are less clear and require further exploration and definition. Areas covered: The evidence that supports NT-3 as a pharmacological target for anxiety and mood disorders is presented and this is followed by a reflection on the quandaries, stumbling blocks, and future perspectives for this novel target. Expert opinion: There is evidence for miRNAs being key post-transcriptional regulators of neurotrophin-3 receptor gene (NTRK3) in anxiety disorders; however, the anxiolytic properties of NT-3 need further examination and delineation. Moreover, NT-3 expression by non-neuronal cells and its role in brain circuits that participate in anxiety and mood disorders require further scrutiny. Further work is vital before progression into clinical trials can be realized.

Citation

A S de Miranda, J L V M de Barros, Antonio Lucio Teixeira. Is neurotrophin-3 (NT-3): a potential therapeutic target for depression and anxiety? Expert opinion on therapeutic targets. 2020 Dec;24(12):1225-1238